The January 2010 issue sets a milestone for the International Journal of Artificial Organs (IJAO). As you may have noticed, a totally new editorial structure that has been agreed upon together with the Board of Governors of the European Society for Artificial Organs (ESAO) and Wichtig Editore, our Publisher, becomes effective with this issue. As compared to the past, the number of Section Editors has been reduced by 25%, and the number of Members serving the Editorial Board has been reduced by 80%. This will allow us to have closer contacts and interactions with all of them, and to jointly plan the future editorial activities of the Journal with all Editors.
Starting from January 2010, it has been also agreed to introduce a policy limiting the term of office in the Editorial Board with the purpose to actively involve a larger number of scientists in the editorial activities of the Blue Journal (the nickname of the IJAO) than it happened in the past. We think that exploration of innovative and often controversial pathways to patients care, and dialogue among scientists engaged in basic and applied research, and among engineers and biologists or clinicians, should be better exploited to match up to the progress and development in fast growing fields such as artificial, bioartificial and tissue engineered organ-based therapies. We would like to adopt this "rotation" policy to involve more young and women investigators who might bring a different perspective, and to have scientists serving the Board with an expertise matching that required by the ad- vancements in science. With their participation, the Blue Journal could indeed become the forum that we envision, where innovative visionary ideas are presented and discussed, where the application of forefront treatments of tissue or organ deficits are explored and evaluated, where side-effects of drugs and treatments for patients with organ deficits are unveiled and techniques are devised to minimize them. With their help, the Blue Journal could consolidate and enhance its function of updating clinicians throughout the world on the most effective and innovative treatment options, and ultimately improve the quality of life of the largest number of patients with tissue and organ deficits. These objectives can only be achieved with high quality contributions, and through the active participation and advice of our Readers and Editors. So, we hope that many of you share our vision and accept this challenge together with us to make the Blue Journal a continuous collaborative and authoritative reference point for scientists who believe in the multidisciplinary evolution of medical treatments to "bridge basic research with clinical application in the field of substitutive and regenerative medicine".
Heaven's waiting on down the tracks/ Oh-Oh come take my hand/ We're riding tonight to the promised land/ Oh-oh Thunder Road -Bruce Springsteen
From the information reported in the inside front cover of this issue, that we invite you to read, you will notice that the mission of the IJAO has been slightly broadened up to include the development and optimization
The beginning of a new era
It is possible that "Heaven's waiting on down the tracks ..." as the song says. We are aware that the competition is tight and it is not going to be easy. Success may wait on us at the end of this track, and we might get "... to the promised land ...", only if you actively support and contribute to our Journal, and help us with your collaboration and advice on new editorial initiatives to make the IJAO unique on the scientific scene. of prosthetic materials, devices and procedures to treat deficits of all human tissues and organs, from the initial conception to the clinical application. The topics of interest have also been expanded and grouped differently to better reflect the intrinsic multi-and interdisciplinary nature, as well as the complexity and multiplicity of the problems addressed.
The energies spent in the renewal of the editorial structure of the Blue Journal may have caused some delay in the manuscript evaluation, for which we deeply apologize. We are glad to communicate that, along with the most important scientific publications worldwide, as of January 1 st 2010, manuscripts can only be submitted and peer-reviewed online through the Editorial Manager platform at: www.editorialmanager.com/ijao Probably, our usual contributors will need some time to adjust to the requirements of the new submission/ review system. However, the use of Editorial Manager will certainly facilitate the manuscript submission and peer-review, thus permitting to easily track the review process of submitted manuscripts in progress. This web-based system will also allow a faster review process of newly submitted papers, and significantly reduce the time from manuscript submission to evaluation, and from submission to publication.
